Search Results - "Nichols, Dave P."
-
1
Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis
Published in American journal of respiratory and critical care medicine (15-02-2020)“…Chronic azithromycin is commonly used in cystic fibrosis based on short controlled clinical trials showing reductions in pulmonary exacerbations and improved…”
Get full text
Journal Article -
2
Cystic fibrosis - Ten promising therapeutic approaches in the current era of care
Published in Expert opinion on investigational drugs (02-10-2020)“…Cystic fibrosis (CF) is a genetic disease affecting multiple organ systems. Research and innovations in novel therapeutic agents and health care delivery have…”
Get more information
Journal Article -
3
Early Aspergillosis in Cystic Fibrosis and Air Trapping: Guilt by Association?
Published in American journal of respiratory and critical care medicine (15-03-2020)“…A study that examines early aspergillosis in cystic fibrosis and air trapping is featured. It offers details of the method of the study that observes…”
Get full text
Journal Article -
4
Developmental Milestones in Pediatric Research: A Case for Including Efficacy as Part of Interventional Trials in Infants with Cystic Fibrosis
Published in American journal of respiratory and critical care medicine (15-05-2019)“…In a study reported in this issue of the Journal, Stahl and colleagues (pp. 1238-1248) provide new evidence for the safety, tolerability, and potential…”
Get full text
Journal Article -
5
Recurrent rhinovirus infections in a child with inherited MDA5 deficiency
Published in The Journal of experimental medicine (03-07-2017)“…MDA5 is a cytosolic sensor of double-stranded RNA (ds)RNA including viral byproducts and intermediates. We studied a child with life-threatening, recurrent…”
Get full text
Journal Article -
6
Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities
Published in Annals of the American Thoracic Society (01-05-2019)“…P. aeruginosa, in particular, is linked to greater airway inflammation and overall decline in health (4, 5). Because of this, strategies to administer…”
Get full text
Journal Article -
7
PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy
Published in Journal of cystic fibrosis (01-03-2021)“…•PROMISE is a large clinical study to measure the impact of ETI by clinical use.•This observational study will measure outcomes over the first two years of…”
Get full text
Journal Article -
8
Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosis
Published in Journal of cystic fibrosis (01-05-2017)“…Abstract Background Concomitant use of oral azithromycin and inhaled tobramycin occurs in approximately half of US cystic fibrosis (CF) patients. Recent data…”
Get full text
Journal Article -
9
Long-term azithromycin use is not associated with QT prolongation in children with cystic fibrosis
Published in Journal of cystic fibrosis (01-03-2021)“…•Long-term trial of chronic azithromycin in children with CF and P. aeruginosa.•Cardiovascular health was measured using electrocardiogram.•Thrice weekly…”
Get full text
Journal Article -
10
Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic Fibrosis
Published in Annals of the American Thoracic Society (01-07-2019)“…The potential of azithromycin to alter the antimicrobial and clinical benefits of inhaled tobramycin in patients with cystic fibrosis (CF) has been previously…”
Get full text
Journal Article -
11
-
12
On the Origin of Lung Cancers
Published in American journal of respiratory and critical care medicine (15-03-2020)“…A study that examines the early changes of lungs that can lead to cancerous transformation. It offers details of the method of the study that uses genomic…”
Get full text
Journal Article